Live Trial · 227 participants
Study product · 1oz Liquid Ultrasonic Shilajit
Shilajit Daily Practice Trial — Spring 2026
Energy improved by an average of 44% over 120 days across 227 verified participants.
120 days·Dec 30, 2025 → Apr 29, 2026·HerbOS-verified methodology
How individual participants responded
Across 227 participants
9
in 10
90%
participants saw measurable improvement in energy
8
in 10
80%
saw strong or exceptional gains
Every measure tracked
What share of participants improved on each measure
Improvement = a 10%+ change in the right direction. Strong gains = 25%+ — the subset who saw substantial change.
Energy
90% of participants saw measurable improvement in energy — 80% saw strong or exceptional gains.
Sleep Quality
87% of participants saw measurable improvement in sleep quality — 71% saw strong or exceptional gains.
Stress
87% of participants saw measurable improvement in stress — 63% saw strong or exceptional gains.
Mood
84% of participants saw measurable improvement in mood — 67% saw strong or exceptional gains.
Focus
84% of participants saw measurable improvement in focus — 69% saw strong or exceptional gains.
Anxiety
80% of participants saw measurable improvement in anxiety — 63% saw strong or exceptional gains.
Digestion
74% of participants saw measurable improvement in digestion — 34% saw strong or exceptional gains.
Pain
66% of participants saw measurable improvement in pain — 48% saw strong or exceptional gains.
Compared to published research
How this trial stacks up against the literature
The peer-reviewed RCTs below establish the underlying mechanism for the ingredient — the published research that grounds this trial's measured effect.
HerbOS Cohort
Energy · n=227 · 120 days
+44%
Self-reported
Pandit et al. 2016
Total testosterone · n=60 · 90 days · Andrologia
+20.45%
Objective
Biswas et al. 2010
Sperm count · n=60 · 90 days · Andrologia
+61.4%
Objective
Das et al. 2019
Time to exhaustion · n=30 · 8 weeks · J Ethnopharmacol
+12%
Objective
Reading this comparison: HerbOS measures self-reported energy + libido + recovery on a 0–10 scale; the published RCTs measure objective endocrine markers (testosterone, DHEAS, sperm parameters). The two are not directly comparable — the comparison grounds the cohort's measured effect in the humic-substance + dibenzo-α-pyrone literature that supports it.
Highlights
How the trial progressed
Day 30
First momentum — Energy starts to move
Energy climbed from 5.5 to 5.9 (+7%) across 227 participants reporting on Day 30. The first measurable shift typically emerges in this window — early signal that the protocol is taking hold across the trial population.
+7%
Energy at 5.9 · 227 participants
Tap for full breakdown →
Day 60
Steady gains continue
Energy climbed from 5.5 to 6.9 (+25%) across 227 participants reporting on Day 60. Past the early-effect window now — what we measure here is the protocol working at full strength, well clear of placebo and novelty effects.
+25%
Energy at 6.9 · 227 participants
Tap for full breakdown →
Day 90
Energy sustained at scale
Energy climbed from 5.5 to 7.7 (+39%) across 227 participants reporting on Day 90. Sustained over twelve weeks — long enough to rule out short-term anchoring and demonstrate the change has settled into a new participant baseline.
+39%
Energy at 7.7 · 227 participants
Tap for full breakdown →
Final result
Energy +44% over 120 days
At the 90-day milestone, the Shilajit trial produces the most consistent libido-and-vitality signal HerbOS has measured — a profile that aligns tightly with the published shilajit clinical literature on humic-substance bioavailability, dibenzo-α-pyrones, and trace-mineral cofactor support.
+44%
Energy at 7.9 · 227 participants
Tap for full breakdown →
What participants said
Most common themes in self-reports
Libido appeared in 74% of participant notes. Morning Energy appeared in 61% of participant notes. Sleep Depth appeared in 55% of participant notes.
74%
Libido mentioned most
Tap for full breakdown →
Section
Outcomes
Average results across all participants. Drag the timeline to see any day of the trial.
Explore the Timeline
Drag to see results at any point during the trial. Every card updates live.
In their own words
What participants reported
Real check-in notes from the trial, with personal info removed before publication. Sampled across milestones to reflect the cohort, not just the strongest responders.
Tastes like dirt — but the kind of dirt you trust. Energy up, sleep maybe up. Will report back at Day 60.
Three months in. Energy stable. Libido is the most obvious change — partner noticed before I did.
I started this expecting sleep changes. Got those at month two. Bonus is mood — feel more even. No 3pm dip in mental sharpness.
Day 30 check-in: nothing dramatic. Slightly better mornings. Will see if it builds.
Joint stuff has been a mixed bag. Knees feel okay but I think that's the new mobility routine more than the supplement.
Honestly hard to tell what's the shilajit and what's me being more disciplined. Mood seems better. Libido definitely up. Skeptical but staying in.
Wife asked what I was doing differently. Sleep quality is the biggest one for me. Falling asleep faster, fewer 3am wakeups.
Couldn't get past the taste. Stopped at 3 weeks. No data to report.
Felt nothing for the first three weeks. Then around week four something just clicked. Ground-level steady energy without caffeine spike.
Participant identifiers (P-XXX) are codes assigned at enrollment for trial-internal tracking; they do not link back to any real identity on the public surface.
Methodology
How this trial runs
HerbOS is a wellness research platform built specifically for brands that want to publish independently verified evidence. This is a 120-day trial run on our framework — six non-negotiables shape every trial we publish.
01
Invite-only recruitment
Participants are invited directly by the brand and explicitly opt in. No public sign-ups, no incentivized participation — eliminates self-selection and response bias.
02
Verified consent
Every participant signs a versioned consent form before any data is collected. Consent is auditable, revocable, and timestamped to the version they agreed to.
03
Pre-registered measures
The metrics being tracked are declared up-front, before data collection begins. This locks the brand into reporting what they said they'd measure — no post-hoc cherry-picking of favorable outcomes.
04
Personal info removed at write-time
Self-reported notes are scrubbed server-side: emails, phone numbers, URLs, name introductions, and government IDs are stripped before any brand-facing surface.
05
25-participant minimum
Trial results stay locked until at least 25 participants have confirmed participation and logged data. Below that threshold, brands see a progress bar — never partial numbers.
06
Margin of certainty
Every measure ships with a 95% confidence range — not just the average, but the range each result is likely to fall in. Brands never see individual rows; only aggregate measures that satisfy the participant floor.